Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?

Vascular mechanisms and manifestations of COVID-19

COVID-19 vasculitis and novel vasculitis mimics.

Letter in response to article in journal of infection: “Cardiovascular complications in COVID-19: A systematic review and meta-analysis”

The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps

Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection

Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups.

Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection

Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy

Arterial disease and venous thrombosis: are they related, and if so, what should we do about it?